Anaptysbio Inc (ANAB) |
|
18.67 -0.37 (-1.94%)
|
06-04 16:00 |
|
Open: |
18.94 |
Pre. Close: |
19.04 |
|
High:
|
19.53 |
Low:
|
18.29 |
|
Volume:
|
417,109 |
Market Cap:
|
509M |
|
|
|
|
AnaptysBio Inc is a biotechnology company. The Company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
19.538 - 19.67 |
19.67 - 19.779 |
|
Low:
|
18.049 - 18.171 |
18.171 - 18.273 |
|
Close:
|
18.488 - 18.69 |
18.69 - 18.857 |
|
Technical analysis |
as of: 2020-06-04 4:28:37 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 24.89 One year: 29.07 |
| Support: |
Support1: 16.83 Support2: 14.06 |
| Resistance: |
Resistance1: 21.31 Resistance2: 24.89 |
| Pivot: |
19.29 |
| Moving Average: |
MA(5): 19.31 MA(20): 19.19 
MA(100): 16.08 MA(250): 28.94 |
| MACD: |
MACD(12,26): 0.66 Signal(9): 0.83 |
| Stochastic oscillator: |
%K(14,3): 48.40 %D(3): 55.62 |
| RSI: |
RSI(14): 51.00 |
| 52-week: |
High: 76.86 Low: 10.00 Change(%): -75.4 |
| Average Vol(K): |
3-Month: 48513 10-Days: 38832 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ANAB has closed above bottom band by 22.9%. Bollinger Bands are 36.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 06 May 2020
AnaptysBio Announces First Quarter 2020 Financial Results and Provides Pipeline Updates - GlobeNewswire
Thu, 21 May 2020
ANAB DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds AnaptysBio, Inc. Shareholders with Losses in Excess of $100000 of Class Action and Lead Plaintiff Deadline: May 26, 2020 - Business Wire
Fri, 22 May 2020
ANAB FINAL DEADLINE TUESDAY: ROSEN, A TOP RANKED INVESTOR FIRM, Reminds AnaptysBio, Inc. Investors of Important May 26 Deadline in Securities Class Action - Business Wire
Thu, 04 Jun 2020
Is It Crazy To Buy AnaptysBio Inc. (NASDAQ:ANAB) And Avis Budget Group Inc. (NASDAQ:CAR) - State Reviewer
Fri, 08 May 2020
Earnings Update: AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance
Mon, 25 May 2020
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - Yahoo Finance
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
27 |
| Shares Float (M) |
16 |
|
% Held by Insiders
|
1.59 |
|
% Held by Institutions
|
104.79 |
|
Shares Short (K)
|
6,110 |
|
Shares Short P. Month (K)
|
6,220 |
Stock Financials |
|
EPS
|
-3.080 |
|
EPS Est This Year
|
-1.990 |
|
EPS Est Next Year
|
-3.060 |
|
Book Value (p.s.)
|
14.690 |
|
Profit Margin
|
|
|
Operating Margin
|
-403.97 |
|
Return on Assets (ttm)
|
-12.6 |
|
Return on Equity (ttm)
|
-19.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
-3.348 |
|
Sales Per Share
|
0.843 |
|
EBITDA (p.s.)
|
-3.386 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-69 |
|
Levered Free Cash Flow (M)
|
-44 |
Stock Valuations |
|
PE Ratio
|
-6.06 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.27 |
|
Price to Sales
|
22.14 |
|
Price to Cash Flow
|
-7.43 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
